Ventyx Biosciences Inc (VTYX)

Currency in USD
2.360
-0.170(-6.72%)
Closed·
After Hours
2.430+0.070(+2.95%)
·
VTYX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VTYX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.3602.598
52 wk Range
0.7833.390
Key Statistics
Prev. Close
2.36
Open
2.56
Day's Range
2.36-2.598
52 wk Range
0.783-3.39
Volume
686.45K
Average Volume (3m)
1.64M
1-Year Change
20.41%
Book Value / Share
3.26
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VTYX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.000
Upside
+408.47%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period

Ventyx Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Ventyx Biosciences Inc Company Profile

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company’s lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for Crohn’s disease. It is also developing Tamuzimod, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor that is in Phase 2a trial for patients with early Parkinson’s disease and is in Phase 2 trial for patients with obesity and additional risk factors for cardiovascular disease. Ventyx Biosciences, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

Compare VTYX to Peers and Sector

Metrics to compare
VTYX
Peers
Sector
Relationship
P/E Ratio
−1.4x−2.3x−0.5x
PEG Ratio
−0.030.010.00
Price/Book
0.7x2.2x2.6x
Price / LTM Sales
-1.6x3.3x
Upside (Analyst Target)
394.1%123.5%43.4%
Fair Value Upside
Unlock19.8%7.1%Unlock

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 12.000
(+408.47% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-0.38 / -0.46
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

VTYX Income Statement

People Also Watch

47.710
ASTS
-7.88%
3.250
ONDS
-2.40%
7.57
ASPN
-8.13%
25.26
CNC
+0.20%
44.680
SMR
-2.72%

FAQ

What Stock Exchange Does Ventyx Biosciences Trade On?

Ventyx Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Ventyx Biosciences?

The stock symbol for Ventyx Biosciences is "VTYX."

What Is the Ventyx Biosciences Market Cap?

As of today, Ventyx Biosciences market cap is 167.94M.

What Is Ventyx Biosciences's Earnings Per Share (TTM)?

The Ventyx Biosciences EPS (TTM) is -1.75.

When Is the Next Ventyx Biosciences Earnings Date?

Ventyx Biosciences will release its next earnings report on 11 Nov 2025.

From a Technical Analysis Perspective, Is VTYX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Ventyx Biosciences Stock Split?

Ventyx Biosciences has split 0 times.

How Many Employees Does Ventyx Biosciences Have?

Ventyx Biosciences has 81 employees.

What is the current trading status of Ventyx Biosciences (VTYX)?

As of 08 Aug 2025, Ventyx Biosciences (VTYX) is trading at a price of 2.36, with a previous close of 2.36. The stock has fluctuated within a day range of 2.36 to 2.60, while its 52-week range spans from 0.78 to 3.39.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.